Log in

CVSI CV Sciences, Inc. OTC · United States

CV Sciences (CVSI) news

CV Sciences, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker CVSI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest CV Sciences news

We have not published a story on CV Sciences yet. When there is news, it will appear here.

CV Sciences annual financials

LineFY2025FY2024
Research and development$122,000$118,000
Net income (loss)-$958,000-$2.4 million
Cash from operations-$407,000-$861,000
Cash and equivalents$278,000$454,000

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $266,000.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about CV Sciences

What is the ticker symbol of CV Sciences?

CV Sciences, Inc. trades under the ticker CVSI on OTC.

Where is CV Sciences listed?

CV Sciences, Inc. is listed on OTC.

Which country or territory is CV Sciences listed under?

Our directory records CV Sciences, Inc. under United States.

Does aibio.space cover CV Sciences?

aibio.space lists CV Sciences, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Is CV Sciences profitable?

CV Sciences, Inc. reported a net loss of $958,000 for the fiscal year ended Dec 31, 2025, and used $407,000 of cash in operations, per its annual report to the SEC.

How much does CV Sciences spend on research and development?

$122,000 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does CV Sciences have?

$266,000 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: CV Sciences

Members talk about CV Sciences (CVSI). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at CV Sciences, newest first. Each line links the filing it comes from.

  1. Listings

    Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.02,5.07,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:CVSI on TradingView.

Listing details

CV Sciences, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker CVSI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
CV Sciences, Inc.
Ticker
CVSI
Listing
OTC
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.